Patients with cystic fibrosis have characteristic disturbances in the electrolyte composition of their sweat, saliva, and pancreatic secretions. We studied the electrical properties of sweat glands in eight patients with cystic fibrosis and in seven normal volunteers to determine the basis of the well-documented inhibition of sodium absorption in this disease. The average electrical potential across 47 sweat glands in the patients was -66.3 +/- 2.1 mV, as compared with -29.8 +/- 3.2 mV for 39 glands in the normal controls (P less than 0.001). The average sweat-secretion rate in 33 glands from six patients was not significantly different from that in 34 glands from six controls, but average concentrations of sodium, chloride, and potassium were significantly higher in sweat droplets from the patients. Calculated rates of both sodium and chloride reabsorption were lower in sweat glands of patients than of normal controls, but chloride reabsorption was more markedly reduced than sodium reabsorption. We conclude that a decrease in epithelial permeability to chloride may explain the characteristic changes in sweat electrolytes in cystic fibrosis and could be a generalized abnormality in the disease.
This article has been cited by other articles:
Rowe, S. M., Accurso, F., Clancy, J. P.
(2007). Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials. Proc Am Thorac Soc
4: 387-398
[Abstract][Full Text]
Quinton, P. M.
(2007). Cystic Fibrosis: Lessons from the Sweat Gland. Physiology
22: 212-225
[Abstract][Full Text]
Olson, D. L., Schwenk, W. F. II
(2004). Nutrition for Patients With Cystic Fibrosis. Nutr Clin Pract
19: 575-580
[Abstract][Full Text]
Wang, X. F., Reddy, M. M., Quinton, P. M.
(2004). Effects of a new cystic fibrosis transmembrane conductance regulator inhibitor on Cl- conductance in human sweat ducts. Exp Physiol
89: 417-425
[Abstract][Full Text]
Granger, D., Marsolais, M., Burry, J., Laprade, R.
(2003). Na+/H+ exchangers in the human eccrine sweat duct. Am. J. Physiol. Cell Physiol.
285: C1047-C1058
[Abstract][Full Text]
Lyczak, J. B., Cannon, C. L., Pier, G. B.
(2002). Lung Infections Associated with Cystic Fibrosis. Clin. Microbiol. Rev.
15: 194-222
[Abstract][Full Text]
QUINTON, P. M.
(1999). Physiological Basis of Cystic Fibrosis: A Historical Perspective. Physiol. Rev.
79: 3-22
[Abstract][Full Text]
GRUBB, B. R., BOUCHER, R. C.
(1999). Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis. Physiol. Rev.
79: 193-214
[Abstract][Full Text]
Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittell, L., Friedman, K. J., Silverman, L. M., Boucher, R. C., Knowles, M. R.
(1994). A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations. NEJM
331: 974-980
[Abstract][Full Text]
Gibson, A., Wagner, L., Collins, F., Oxender, D.
(1991). A bacterial system for investigating transport effects of cystic fibrosis--associated mutations. Science
254: 109-111
[Abstract]
Rommens, J., Iannuzzi, M., Kerem, B, Drumm, M., Melmer, G, Dean, M, Rozmahel, R, Cole, J., Kennedy, D, Hidaka, N, al., e.
(1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science
245: 1059-1065
[Abstract]
Riordan, J., Rommens, J., Kerem, B, Alon, N, Rozmahel, R, Grzelczak, Z, Zielenski, J, Lok, S, Plavsic, N, Chou, J., al., e.
(1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science
245: 1066-1073
[Abstract]
Heinz-Erian, P, Dey, R., Flux, M, Said, S.
(1985). Deficient vasoactive intestinal peptide innervation in the sweat glands of cystic fibrosis patients. Science
229: 1407-1408
[Abstract]
Brouillard, F., Bouthier, M., Leclerc, T., Clement, A., Baudouin-Legros, M., Edelman, A.
(2001). NF-kappa B Mediates Up-regulation of CFTR Gene Expression in Calu-3 Cells by Interleukin-1beta. J. Biol. Chem.
276: 9486-9491
[Abstract][Full Text]
Previous
